Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Core Insights - Aurinia Pharmaceuticals has experienced management changes, but activist investors believe these changes are insufficient despite the upward trend in Lupkynis sales [1] Company Overview - Aurinia Pharmaceuticals is focused on the sales performance of its product Lupkynis, which continues to show growth [1]